Gene | Population | No. of cases | No. of controls | Genotype | Allele | Association with RA | Reference |
---|---|---|---|---|---|---|---|
MIR146A | Egyptian (this study) | 52 | 49 | CG | C | Protective | |
Chinese | 126 | 102 | No association | [11] | |||
Iranian | 104 | 110 | No association | [19] | |||
Polish | 111 | 130 | No association | [20] | |||
Caucasian and Asian | 2660 | 4098 | No association | [21] | |||
Han Chinese (Sichuan) | 208 | 240 | No association | [22] | |||
Egyptian female (Zagazig) | 217 | 245 | No association | [23] | |||
Greek | 136 | 147 | No association | [24] | |||
Chinese (Changzhou) | 600 | 839 | No association | [25] | |||
MIR499, MIR499A | Egyptian (This Study) | 52 | 49 | No association | |||
Chinese (Jiangsu) | 214 | 478 | No association | [26] | |||
Han Chinese (Anhui) | 386 | 576 | No association | [27] | |||
Iranian | 104 | 110 | TC | C | Protective | [19] | |
Caucasian and Asian | 2660 | 4098 | TC | C | Susceptible in Caucasian, No association in Asian | [21] | |
Egyptian (Suez Canal) | 100 | 100 | TC | C | Susceptible | [7] | |
Egyptian female (Zagazig) | 217 | 245 | TC | T | Susceptible | [23] | |
Han Chinese (Sichuan) | 208 | 240 | No association | [22] | |||
MTMR3 | Egyptian (This Study) | 52 | 49 | CT | C | Susceptible | |
MIR155HG | Egyptian (This Study) | 52 | 49 | AT | Protective while excluded | ||
Egyptian (Zagazig) | 100 | 100 | AT | A | Susceptible | [28] | |
IRAK1 | Egyptian (This Study) | 52 | 49 | CA | Susceptible while excluded | ||
Chinese (Jiangsu) | 214 | 478 | CA | A | Susceptible | [26] | |
Han Chinese (Anhui) | 386 | 576 | CA | C | Susceptible | [27] | |
Greek | 136 | 147 | CA | C | Susceptible | [24] | |
Iranian | 120 | 120 | No association | [29] | |||
PADI4 | Egyptian (This Study) | 52 | 49 | CT | Susceptible while excluded | ||
Iranian | 150 | 150 | CT | T | Susceptible | [16] |